COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases -
-
COMMUNIQUÉ DE PRESSE
Ascendant Resources Notifies Shareholders Of Upcoming Special Meeting
Ascendant Resources Inc. announces special meeting for shareholder vote on acquisition by Cerrado Gold Inc. under Section 182 of the Business Corporations Act (Ontario) and recommends FOR vote. Proxies due May 2, 2025 -
COMMUNIQUÉ DE PRESSE
Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
NanoViricides, Inc. commences evaluation of clinical drug NV-387 for Measles virus treatment, utilizing innovative nanomedicine technology. Company aims to combat Measles outbreak and provide effective antiviral solution -
-
-
COMMUNIQUÉ DE PRESSE
Cerrado Gold Provides an Update on Fiscal Policy Changes in Argentina Including Removal of Currency Controls on April 14th
Argentina to lift Capital Controls on April 14, receiving $20B from the IMF, $12B from World Bank, and $10B from Inter-American Development Bank. Currency set to float in 1,000-1,400 Pesos range, simplifying capital flows
